Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Sonia Anand, Associate Vice-President Global Health, McMaster University

Whose health matters? The diversity deficit in clinical trials

Racialized people are dsproportionately affected by diabetes, but are underrepresented in clinical studies. (Shutterstock)

Most people are aware that the process of bringing new medical products to market is rigorous, complex and tightly regulated. Diagnostic tests, therapies and treatments all go through lengthy, expensive trials to make sure they’re safe and effective before being approved for public use. The gold standard for clinical trials — randomized controlled studies — often require thousands of research subjects.

Society generally agrees such effort is necessary. Our medical system is built on evidence and trust, and reliable research is essential to both.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.